Discover answers to your questions with Westonci.ca, the leading Q&A platform that connects you with knowledgeable experts. Get detailed and precise answers to your questions from a dedicated community of experts on our Q&A platform. Our platform provides a seamless experience for finding reliable answers from a network of experienced professionals.
Sagot :
Neurodegenerative disorders like Alzheimer's disease and Parkinson's disease are characterized by the progressive atrophy and loss of neuronal function.
- Lack of knowledge of the essential molecular pathways that cause neurodegeneration is one of the major barriers to the development of neuroprotective medicines for Parkinson's disease and other neurodegenerative illnesses.
- A deeper understanding of the diseases' molecular processes is urgently required.
- The lack of suitable in vitro models is a significant barrier to the creation of innovative neuroprotective therapies and the identification of early illness biomarkers.
- Furthermore, the majority of the ones that are available do not have active neuron-glia interactions. However, it is generally known that astrocytes are essential to both a healthy brain and to pathology, therefore their absence affects the applicability of these models.
Learn more about the neurodegenration with the help of the given link:
https://brainly.com/question/13047924
#SPJ4
We appreciate your time. Please come back anytime for the latest information and answers to your questions. Your visit means a lot to us. Don't hesitate to return for more reliable answers to any questions you may have. Westonci.ca is committed to providing accurate answers. Come back soon for more trustworthy information.
